In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 1st, 2006 | 30 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | -0.16 | -10.15 | -18.09 | 8 | 11 | 0 | 201 | 422.342 | 2 | ↓ |
Hi High (pH 8-9.5) | -0.16 | -9.24 | -52.65 | 7 | 11 | -1 | 204 | 421.334 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | EP0320227A2; EP0320227B1; EP0496349B1; EP0793476A1; EP0888052A1; US4436732; US4518592; US4933399; US5241022; US5773004; US6113907; WO1996016632A1; WO1997034482A1; WO1997039355A1; WO1999021005A2 | IBM Patent Data |
Target | Hsp90 co-chaperone Cdc37(Q16543)&Telomerase protein component 1(Q99973)&Telomerase reverse transcriptase(O14746)&Interleukin-1 beta(P01584) | Herbal Ingredients Targets |